Ledger.Open graph →

SEC Form D · Amendment · filed May 13, 2015

Alpine Immune Sciences, Inc

Offering

$1.3M

Sold

$1.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Ryan H. Swanson · Seattle, WAExec · Director David H. Miller · Seattle, WAExec · Director Dr. Mitchell H. Gold · Seattle, WAExec · Director Michael H. Kornacker · Seattle, WAExec · Director Bradley D. Ginesin · Kent Cliffs, NYExec · Director Stefan W. Magel · Kent Cliffs, NYExec · Director Joseph M. Manko, Jr · Philadelphia, PAExec · Director Neil O. Shotton · Tempe, AZExec · Director Bruce A. Margulis · Tempe, AZExec · Director Jeffrey S. Serkes · Tempe, AZExec · Director Joseph A. Nathan · Tempe, AZExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗